How can clinical research networks support developers of medicines for children?

EMA

16 November 2016 - Event to be broadcast live on 1 December 2016.

The EMA is organising a one-hour webinar on 1 December 2016, starting at 14:30, which aims to showcase to pharmaceutical companies the benefits of working with the European Network for Paediatric Research at EMA (Enpr-EMA) and the clinical research networks it represents in the development of medicines for children.

The speakers at the event are Mark Turner, Chair of Enpr-EMA and Co-Chair Irmgard Eichler who will outline the role of EMA in this network and the practical support Enpr-EMA can offer to developers of paediatric medicines.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder